Risankizumab (anti-IL-23)

製品コード：A2046 Batch: A204601

Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.

製品説明

CAS No.	1612838-76-2
Formulation	PBS Buffer, PH 7.4
Isotype	human IGg1, κ
Application	Risankizumab (anti-IL-23)
Source	CHO
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping	Shipped under low temperature conditions
Purity	98%
Protein concentration	6.4mg/ml
Endotoxin Level	＜1EU/mg

カスタマーフィードバック

人間や獣医の診断であるか治療的な使用のためにでない。